Feasibility of a New Technology for Isolating Circulating Tumour Cells
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: HER2-positive Metastatic Breast Cancer|Ovarian Cancer|Hormone-resistant Prostate Cancer|Circulating Tumor Cell
Interventions: PROCEDURE: Blood sample collection
Sponsor: Centre Oscar Lambret